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Next-generation sequencing has evolved during the past 10 years to become the go-to method for
genome-wide analysis projects. Based on parallelizable PCR methods adopted from the traditional
Sanger sequencing, NGS platforms can produce massive amounts of genetic information in a single
run and read an entire DNA molecule within a day. The immense amount of nucleotide sequence
data produced by a single sample has brought us to an era of algorithmic optimization for analysis
and ﬁguring out parallelization schema. For cohort projects generally cloud based systems are used
due to vast computing power requirements.
Anduril is an integration and parallelization framework well suited for NGS analysis, as is shown
in this study. After a brief review of the golden standard methods of NGS analysis, we describe
the incorporation of the main tools into the new sequencing bundle for Anduril. Tools for align-
ment (BWA, Bowtie), recalibration (GATK, Picard-tools) and variant calling (GATK, Samtools,
VarScan) are in main focus. The Best Practice of Broad Institute, creators of The Genome Analysis
Toolkit (GATK), has been a big inspiration in the creation of our sequencing pipeline.
The evolution of sequencing bundle tools into a pipeline is discussed through three separate project
examples. First, a small group of 8 chronic myeloid leukemia patient samples were analysed after
implementation of the main tools of the pipeline. The results were consistent with previous results,
but no novel relevant mutations were found. Second, exome sequencing data from 180 breast
cancers with controls available in TCGA (The Cancer Genome Atlas) were processed for use in
various projects in our lab. The example showed the power of Anduril in gross cohort analysis
projects, enabling automatic parallelization and intelligent workﬂow management system. Third,
we analysed exome data from 330 TCGA ovarian cancers with controls and created a prototypical
set of database components for creation of a database of annotated variants for use in analytical
queries.
Compared to other integration frameworks (e.g. GATK, Crossbow and Hadoop), Anduril is a
robust contender for the programming oriented scientist. As cloud computing is becoming at an
increasing rate a requirement in large genome-wide analysis projects, Anduril provides an eﬀective
generalizable framework for adding tools, creating pipelines and executing entire workﬂows on multi-
nodal computing servers. As technology advances and available computational resources grow,
fast multi-processor analysis can be incorporated into health care more and more for detection of
disease causing genes, medication kinetics altering polymorphisms and cancer driving mutations in
an everyday setting.
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Deﬁnitions
Alignment = A list of reads arranged according to the sequence of the reference
genome.
Alignment quality = Generally estimated using the average depth and overall cov-
erage.
Base space = The only possible real values in a DNA sequence of nucleotide bases
are {A, T, G, C}.
Base quality = A PHRED quality score given to each nucleotide base during se-
quencing as an estimate of the probability that it is the correct base.
BAM = Compressed Binary SAM (Sequence Alignment Map) ﬁle that allows ef-
ﬁcient calculations in reduced ﬁle size and is used in alignment processing
steps.
Call = One (SNV/SNP) base or a sequence of numerous (SV/indel) bases in the
alignment that is evaluated to diﬀer from that in the reference in the same
locus (i.e. is a variant).
Cloud computing = Shared service of processing resources providing computing
power for users on demand.
Coverage = The percentage of the reference genome that is covered by the se-
quences in a read or alignment ﬁle. The term is often, a bit confusingly, used
as a short version for depth of coverage, which means the average depth of
sequencing. For example, a coverage of >100x means that on average, each
genomic location is covered by at least 100 reads.
CSV = The (comma-separated value) table ﬁle format that the Anduril engine
uses as standard for manipulations and most components handle inherently
for inputs and outputs.
dbSNP = The consensus database of single nucleotide polymorphisms (SNPs).
Depth = Number of reads in an alignment that cover a speciﬁc area. For an entire
alignment ﬁle, it is deﬁned as the mean depth and can be used as a quality
metric.
iv
FASTQ = The standard (FASTA with Qualities) ﬁle format for raw reads with
base quality estimates created by sequencer platforms.
GATK = The Genome Analysis Toolkit, created and maintained by Broad In-
stitute, which is the golden standard software package used in sequencing
projects.
Germline = Inherited (or de-novo changes around conception) genetic variations
are called germline mutations. Germline mutations are analyzed in studies of
genetic diseases other than cancer.
Haplotype = Multiple deﬁnitions exists. Primarily, a haplotype is a group of genes
that are inherited together from a single parent. By a second deﬁnition, a
haplotype is a set of SNPs in a chromosome that statistically always seem to
occur together. Lastly, haplotype can refer to a collection of speciﬁc mutations
in a genetic segment.
Illumina = A sequencer platform technology that creates short-reads of around 100
bases in length.
Indel = Common term for genetic insertions and deletions, which are short oligo-
nucleotide changes in the amount of bases in a genes and generally occur
through errors made by DNA polymerase or DNA repair enzymes.
Locus = A genomic position with respect the chromosomal coordinates of the
reference genome.
Mapping = The ordering of sequenced reads according to the coordinates of the
reference genome. The alternative to mapping is de-novo assembly.
Next-generation sequencing platform = An automated sequencing machinery that
parallelizes the same principle used in Sanger sequencing. Entire DNAmolecules
can be analyzed in a single run within a day.
Paired-end sequencing = A method were the two ends of a DNA fragment of a
certain length are sequenced. The distance of the coupled mates is assumed
constant, which aids in analysis of structural information.
Picard-tools = A set of command line tools, that allow numerous sequencing ﬁle ma-
nipulations such as sorting, merging, splitting, duplicate marking and quality-
metric calculations.
vRead = The fragment unit of a speciﬁc (usually constant) length of nucleotide
bases that is read by a NGS platform and written into the list of millions of
reads compiled during a single run.
Roche-454 = A sequencing platform that (using pyrosequencing) produces long
reads of around 500 bases in length.
Sanger sequencing = The in vitro method developed by F. Sanger in 1977, in
which chain terminating (dideoxy)nucleotides and DNA polymerase enzymes
are used with ﬂuorescent dyes to read DNA sequences of up to several hundreds
of bases. The method is still widely used for small-scale analysis and for
validation of NGS results.
Sequencing = The process of determining the exact order of nucleotides within a
DNA molecule.
Sequencing bundle = A set of components for Anduril created for use in NGS
analysis pipelines.
SNP = Variations in the human population of one base length that are known to
occur with a certain (ethnicity dependant) mean frequency.
SOLiD = A (Sequencing by Oligonucleotide Ligation and Detection) NGS platform
that produces short reads of about 100 bases in length in colorspace.
Somatic = Uninherited mutations in cells of the body that happen during a life-
time that, when disturb cell stability and growth, can cause cancer. Somatic
mutations are analyzed in cancer studies.
Synthetic lethality = Creates cell death when two or more gene products are defect,
however not when only one is deﬁcient. As somatic cancer mutations create
countless silent random genetic defects, those that aﬀect synthetic lethality
partner genes can hypothetically be exploited as therapeutical targets for
achieving speciﬁc cell death of cancer cells, while leaving normal host cells
intact.
Variant calling = The algorithmic step that calculates the calls, generally by build-
ing a (Bayesian or other) probabilistic model using prior information, such as
normal genetic mutation frequency depending on molecular context.
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1 OVAC BRCA1/2 Mutations
11 Introduction
Modern cancer research and clinical genotyping relies heavily on vast computational
power and eﬃcient algorithms. Capillary methods and panel micro-arrays are still
used when locations of interest are known and are for this purpose the golden stan-
dard. For genome wide analysis however, the traditional methods are too time
consuming. The Human Genome Project was concluded during an era where DNA
shotgun methods were combined with Sanger sequencing [San75], which required
analysis of small pieces of DNA in parallel resulting in a huge assembly problem to
be solved [Ven01, Lan01].
Now, when the complete consensus genome sequences are known for all frequently
studied species, they can be used as templates for rapid recreation of the entire
genomic sequences of individuals. Next-generation sequencing (NGS) methods still
split the genome into pieces that need to be assembled, however the sequencing of an
entire genome is usually done on a single machine and assembly on a single computer
unit using the known consensus genomic sequence of the species as reference [Mar13].
Further processing of the mapped genome, the so called alignment [Li09b], relies
on numerous computational steps based on mathematical improvement of the reads
for achieving optimal variational analysis [Liu12]. Each base is compared to the
reference for detection of alternate alleles. Multiple bases are compared as a unit
for identiﬁcation of insertions, deletions and structural variations [Yoo09, Abe13,
Gho14, Alk15]. Reliable calls are inferred through utilization of known variation in
the population and appropriate ﬁltering steps.
A complete DNA sample can today be analyzed on a single modern computer within
a day. Multi-sample analysis however, increases sensitivity and speciﬁty, but has
a much larger computational requirement for which cloud-based systems are used
[Lan09a, McK10]. To make analysis pipelines stable and reusable numerous eﬀorts
have been made by separate groups. In this thesis we will show how the robust
parallelizable sequencing pipeline for the Anduril framework [Ova10] was created
and tested.
The history of sequencing and progression to NGS will be reviewed in the background
section, in which we will also discuss the current golden-standard methods of NGS
algorithms and software. The incorporation of the most relevant NGS procedures
into our pipeline and their usage will be examined in the methods section. The
ﬁnal sequencing pipeline shown in ﬁgures 2 and 3 is a result of months of work
2and further months of testing in three separate projects, spanned over a few years.
The experimental projects are discussed in detail the results section. The ﬁnal
result is a powerful sequencing pipeline incorporated into a downloadable bundle of
components in Anduril [Ova16].
Cancer biology and genetics is out of scope for this study and only the most rel-
evant terminology will be explained. The Hallmarks of Cancer [Han00, Han11],
however, provides an ultimate theoretical basis for the exploration of cancer driver
genes [You11] and therapeutical targets, which is the main motivation for this
work. Synthetic lethal genes provide especially interesting targets for treatment
[Kot08, Wan16a]. With technological advances we could fathom a future where,
hypothetically, cancer could be treated as (multi-cellular) parasites and eradicated
using a vast set of antibiotics, each with diﬀerent synthetic lethal partner products
as targets. The treatment problem would then be reduced to that of ﬁnding the can-
cer mutation targets dynamically, e.g. through monitoring of circulating mestatatic
cells from blood samples, and fast, as the cancer cells are continuosly changing the
tumor landscape.
2 Background
Next-generation sequencing (NGS) has evolved from Sanger sequencing [San75],
developed in 1977, during a span of roughly 40 years. Primary Sanger methods
are still used for small-scale projects and for validation purposes of NGS results.
More comprehensive validations are commonly done using microarray analysis, in
which ﬂuorescent hybridization is used on matrix plates containing known probes of
complementary sequences. Microarrays are extremely reliable and still functions as
more of a parallel method than a stepping stone compared to NGS [Iri07].
Even though microarrays have obvious structural design bias limiting ubiquitous
genome-wide investigation, they still provided the ﬁrst methods in expression, chro-
matin structure, SNP genotyping and methylation analysis. NGS methods have
however grown to take over most of these previously golden-standard techniques by
providing unbiased and extended information. Due to the low cost and speed of
microarray analysis they are still the mainstream of clinical screening, where the
locations of interest are obvious, along with direct loci PCR of speciﬁc genes.
The basic concept of NGS analysis is depicted in ﬁgure 1. In short, an individual
sample of DNA is processed in a series of steps until variation from the reference
3genome can be inferred, from which mutations of interest (e.g. disease causing) are
mined among millions of candidates. In this chapter we will brieﬂy discuss the evolu-
tion of NGS, the common methods of analysis and introduce the Anduril framework.
This provides a ground basis for the sequencing pipeline that was created, which will
be described in the subsequent section. The nomenclature for variational studies is
well established [den01] and the relevant terminology (words in cursive throughout
the text) is summarized in the Deﬁnitions section.
2.1 Sequencing
By deﬁnition sequencing means analysis of parts or the complete sequence of nu-
cleotides in a DNA molecule. Unless de-novo building of the sequence is otherwise
required, normally the order of nucleotides is derived by comparing and mapping
the separate parts to a reference genome [Tra09]. A suitable reference is achieved
through pooling of well spaced candidates of a species and calculating the average
nucleotide at each locus. After the sequence is mapped, the corresponding variation
from the reference can be inferred and studied [Dal10, Ng10]. Inherited (germline)
variations cause all phenotypical diﬀerences in a species and the relative or absolute
risks for diseases. The uninherited (somatic) variational changes however is the area
of study of cancer genesis and treatment targets.
The complete consensus 2.9 Gb sequence of bases of the human genome was solved in
The Human Genome Project, which was concluded in 2001, using the whole-genome
shotgun sequencing method [Ven01, Lan01]. The International HapMap project
further identiﬁed 3.1 million common SNPs in the human population and a website
of tools for accessing the respective haplotypes was created [The03, Tho05, The07].
The consensus human genome is now universally used as a reference sequence in
human next-generation sequencing projects. HapMap together with other gathered
resources, such as Ensembl [Cur04], RefSeq [Pru07] and UCSC [Hsu06] gene portals,
are regularly utilized in the consequent analysis for adding information about the
data.
The golden standard capillary Sanger method of sequencing naturally evolved start-
ing from 2005 through automation and parallelization into next-generation sequenc-
ing (NGS). NGS is an automated process incorporated into a single machine that
can read an entire (human) genome within a day. Using a NGS platform, e.g. Il-
lumina (Illumina Inc., Ca, USA), Roche-454 (454 Life Sciences/Roche, CT, USA)
or SOLiD (ABI Solid Sequencing/Life Technologies, CA, USA), the DNA-molecules
4Figure 1: The basic concept of next-generation sequencing. DNA molecules are ﬁrst
fragmented and the pieces ampliﬁed and sequenced, all done in a automated sequenc-
ing machine. Quality control procedures are commonly required for raw reads after
sequencing, such as low-quality end trimming and platform-speciﬁc ﬁlters. Next,
the reads containing nucleotide sequences are mapped to a reference genome and
the variants called using genotyping algorithms. Finally, the calls are ﬁltered using
annotation information and computational methods. The acquired variants are now
ready for genetic interpretation. The coloring demarcates the transition between
pipelines and separates data from results. The blue (purely computational) pipeline
is the main topic of this study.
5of an individual are ﬁrst fragmented and the pieces of nucleotides ampliﬁed using
parallel PCR. The clones of fragments are read using incorporated ﬂuorescent dye
scanning methods into base space (A, T, C and G). [Ben08, Mar13]
The acquired reads, consisting of a varying amount of partly overlapping sequences
(depending on the coverage used) of parts of the original DNA sequence, are ready
to be assembled into the complete original sequence in base space. The variational
analysis that follows requires a NGS framework of eﬃcient software (the pipeline)
and robust hardware of processors, memory and storage space, which for big cohort
projects usually means a cloud computing system [Lan09a].
2.2 NGS frameworks
For a sequencing project to succeed an eﬀective setup both software- and hardware-
wise is required. Numerous software using various algorithms exist for each step of
the process, most of which started to arise quickly after the development of the ﬁrst
sequencing platforms [Abe13, Gho14, Dal10, Nev15]. Choosing the correct tools can
be diﬃcult and connecting them together with the right amount of resources even
harder. Multiple ready-to-use workﬂows have been made to help out the newcomer.
A sequencing project usually follows the workﬂow of 1. alignment, 2. recalibration,
3. variant calling and 4. ﬁltering and annotation, depicted in more detail in ﬁgure
2.
Next-generation sequencing frameworks have been well reﬁned over the past 6 years.
More often than not, the tool creators have tackled a speciﬁc part of the process,
such as (germline and/or somatic) variant calling (VarScan [Kob09, Kob12]), indel
speciﬁc calling (Pindel [Ye09, Gho14]) or alignment (Burrow-Wheeler Aligner or
BWA [Li09a, Li10] and Bowtie [Lan09b, Lan12]). Others have tried to create a more
comprehensive package that include tools for both alignment and variant level data,
e.g. The Genome Analysis Toolkit (GATK) [McK10, DeP11, dAA13], Samtools
[Li09b], Crossbow [Lan09a]) and Hadoop [Agg15].
Any of these can be, and many have been, incorporated as components into the
integration framework of Anduril [Ova10]. Anduril enables a powerful creation of
an entire NGS pipeline using a common programming language and powerful engine
for running the analysis with automatic parallelization on practically any system.
6Figure 2: The basic workﬂow of the computational part in next-generations se-
quencing. The FASTQ (FASTA with Qualities) reads from a sequencer or database
(e.g. The Cancer Genome Atlas, TCGA) are after quality control (QC) procedures
mapped to the reference genome using an aligner software. The alignment in Binary
SAM format (BAM) is next recalibrated and realigned using the Genome Analysis
Toolkit (GATK) and marked for PCR duplicates using Picard-tools. The variants
are next genotyped using a caller software. The calls in Variant Call Format (VCF)
are ﬁnally ﬁltered preferably using machine learning if enough data is available
(GATK) and annotated using various databases (Annovar, Moksiskaan). The ﬁnal
result is often presented in a PDF or tabular CSV (comma-separated value) ﬁle.
The oval steps are parts of the sequencing pipeline, with colors emphasizing changes
in data types. The green boxes summarize software, method and data information
that is used in the pipeline.
72.3 Anduril
Anduril is a simple yet powerful programming framework created for large-scale
data analysis. The Anduril engine handles the execution of the pipeline and the
ﬂow of information in the form of reading and writing ﬁles. The engine keeps
track of ﬁle changes (the information ﬂow) and re-executes only the parts of the
pipeline that have changed in each run. The pipeline is written in Scala (previously
in AndurilScript) in a workﬂow ﬁle, which deﬁnes the pipeline components using
logical connections.
The scripting language (Scala/AndurilScript) itself is easy to learn for any scientist
and is used for connecting components together into a pipeline, handling of workﬂow
parameters, looping for multi-threading and result creation e.g. in the form of a
PDF or website. The engine automatically uses all available processors in a multi-
threaded fashion and allocates necessary memory, by launching separable executions
in their own threads. The engine will keep track of the threads and wait at merging
points when required by following the logic of the pipeline. The processes run in
succession and in parallel until the entire pipeline execution is ﬁnished. Since the
engine remembers its state of execution, if errors occur or the workﬂow is stopped
and changed in mid-process, only those steps that are changed or have yet to be run
are executed on the next run.
The Anduril framework is especially well suited for next-generation sequencing
projects. As we can see in ﬁgure 2, a NGS pipeline contains numerous compu-
tational steps that need to be linked together. Parameters often need to be adjusted
according to the data at hand and possibly re-iterated during searching of the op-
timal setup. For sample cohorts containing hundreds of samples, a multi-threaded
approach with fully parallelizable executions is superior to non-parallelizable frame-
works.
New components with documentation are created and shared on a regular basis.
Anduril is available under an open source license and is actively maintained with
new versions released regularly. A graphical interface for easy pipeline creation
and running that implements Scala/AndurilScript intrinsically has been available
since 2014. New components can be created using various programming languages,
for instance R, Java, MATLAB, Python and Perl or simply as Scala/AndurilScript
functions that run already existing software.
For next-generation sequencing projects the sequencing bundle was created, which
8currently incorporates a complete set of functions that run separate golden standard
NGS tools and are easy to include into any sequencing pipeline.
3 Methods
In this chapter we will explore the design of the next-generation sequencing pipeline
incorporated into the Anduril framework, by looking at each pipeline step separately.
For more detailed component descriptions, please see the Anduril documentation
[Ova16], as only the main points will be reviewed here. The pipeline follows the
principles of the current golden standard workﬂow established by Broad Institute
[Bro16]. The component development for Anduril NGS studies began 2011 and is
still ongoing as the ﬁeld is ever changing. Finished and ready-to-use components are
incorporated in a separate sequencing bundle. The components have already been
used in various projects (see section 4) and are regularly updated for keeping up
with new software versions of the tools used. The overall pipeline can be seen in
ﬁgure 2.
3.1 Sequencing data
A standard raw NGS data ﬁle uses either the FASTQ or unaligned BAM format,
which typically contain millions of reads created by a NGS platform. The raw reads
are fed into the NGS analysis pipeline for processing. Unless a NGS platform is
available through collaborators, data ﬁles can be downloaded from public databases
such as The Cancer Genome Atlas (TCGA) with license (see ﬁgure 2 step 1) [Chi08].
A typical ﬁle size spans from 1 to 300 Gb depending on genome size and sequencing
depth and coverage. A typical human exome data sample is roughly 30 Gb in
ﬁle size, while a corresponding whole genome ﬁle is around 10 times as big, due
to 100 times larger genomic coverage, but 10 times lower depth. The burden on
data storage architecture and management in cohort projects is evident. Exome
sequencing, covering only around 1 % of the genome, has been a compromise in
order to achieve excellent read depth (around 50-200x), with much less demand on
computer and NGS platform resources. [Hod07, Ng10, Zha14]
FASTQ ﬁles contain (millions of) lines with read name and platform ID paired with
the sequence of bases read and corresponding base qualities evaluated during the
platform run [Coc10]. The number of bases in each read is typically constant and
9dependent on the platform architecture used. Illumina creates around 100 bases
per read, while the long reads of Roche-454 generally contain roughly 500 bases.
The BAM (Binary Sequence Alignment Format, i.e. binary SAM [Li09b]) ﬁles are
tabular and contain multiple ﬁelds of additional information. During alignment of
an unaligned BAM ﬁle, only the information contained in an equivalent FASTQ ﬁle
is used.
In order to retain structural information paired-end sequencing is now most com-
monly used. Paired-end data is stored in two FASTQ or BAM ﬁles with equal
amount of lines, where each read in the ﬁrst ﬁle has a corresponding mate read
in the other ﬁle. The pairs are created by reading each end of a longer sequence
usually with a constant genetic distance in between. When the mate distance varies
compared to the assumed reference distance structural information can be inferred.
[Ful09]
3.2 Alignment
The raw reads in a FASTQ or BAM ﬁle are aligned to a reference genome as the
ﬁrst step of analysis (see ﬁgure 2 step 3). Numerous pre-processing qualiy-control
steps are often used after sequencing before mapping (step 2 in ﬁgure 2), but are
not proven to be unequivocally eﬀective, the most popular being read trimming
of low-quality ends [Liu12]. Quality control is not covered further in this work,
however various QC components are available in Anduril, with most developed for
RNA sequencing. The alternative to alignment is de-novo assembly of the genome,
which introduces a diﬀerent set of problems that are continuously addressed by new
enhanced algorithms [Cha15]. De-novo assembly is not covered by this study, as it
is still quite experimental and not widely used in practical medical applications due
to higher error rates.
For alignment the Align component for Anduril was made. Align takes as input the
reference genome to which the reads will be mapped (e.g. The Genome Reference
Consortium Human genome build 38 [Lan01]) and the reads in either one single-end
ﬁle or two paired-end data ﬁles. The most common aligners BWA, Bowtie(2) and
TopHat(2) (for RNA-sequencing) are supported [Tra09]. By setting parameters the
appropriate aligner can be chosen, as well as additional information such as sample
name, sequencing platform ID, trimming value and seed length.
The sample name and platform ID are stored in the resulting BAM in the header.
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Naming the samples helps when using merging and splitting procedures later on
and when doing multi-sample analysis e.g. with GATK. The platform ID is re-
quired when using GATK, which parametric assumptions depend on the sequencing
technology used. Trimming from both ends can be applied by aligners dynamically
using base length (Bowtie) or base quality (BWA) criteria. Seeding enables the us-
age of only a speciﬁc number of bases from the high-quality end when determining
the alignment, which speeds up the process signiﬁcantly.
The resulting BAM alignment ﬁle contains the aligned reads ordered by location
according to the chromosomal coordinates of the reference genome. Depending
on the aligner used the sorting is done innately or separately automatically using
Picard-tools using default settings with modiﬁable memory-allocation. The aligned
and sorted BAM ﬁles is now ready for recalibration.
3.3 Recalibration
The aligners use a crude, memory eﬃcient and fast algorithmic approach in order
to ﬁnd the ﬁrst best genomic match(es) of each read to the reference. The raw
alignment will contain systematic biases that can be corrected in the recalibration
step. First, duplicate reads created in the PCR reaction during preparation for
sequencing will be aligned by a crude algorithm along with all other reads. This will
make interpretation of depth for variation analysis problematic unless separately
accounted for. Second, misalignments occur due to problematic regions, such as
indel, structural variant, and repetetive regions.
Lastly, the original base qualities calculated by sequencers are good estimates of the
process accuracy itself, but are generally poor for transforming into variation quality
after calling due to various biases, such as the position in the read (position bias)
and known background variation in the population (polymorphism bias). These
three problems are taken into account in the stepwise recalibration process (step 4
in ﬁgure 2), which is recommended for most sequencing studies. [Liu12, Pir14]
3.3.1 Duplicate marking
The duplicate marking algorithm of the Picard toolkit was incorporated in the Du-
plicateMarker component, which takes the sorted alignment BAM ﬁle created in the
alignment process and the reference genome as input ﬁles. The output will be a du-
plicate marked ﬁle, where either the duplicate reads have a ﬁeld added for dynamic
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ﬁltering, or optionally the duplicate reads are removed altogether. A metrics ﬁle is
also output containing statistics such as the count of duplicates found, which can
be useful to incorporate in the ﬁnal project report.
3.3.2 Realignment
The realignment procedure uses the two-step process of GATK and is included in
the Realigner component. The component takes as input the reference genome and
the (sorted and duplicate marked) alignment BAM ﬁle. The output is a realigned
BAM ﬁle and a list of the regions that were targeted for manipulation. For case-
control analysis paired tumor and normal samples are preferably input together for
combined realignment in order to keep both alignments positionally coherent, which
helps in comparison analysis later on. Data ﬁles of known indel regions (e.g. from
1000 Genomes Project [Alt15]) and known SNP variation (from dbSNP [She99]),
which are available through the Broad Institute server, should be used to aid the
algorithm [Bro16].
3.3.3 Base quality score recalibration
The most comprehensive recalibraton step is the correction of base qualities. For-
tunately GATK includes an advanced algorithm based on machine learning for ad-
justing the original qualites, which takes into account numerous biasing covariates.
Using before-and-after covariate plot comparisons, a clear improvement of qualities
through the adjustment according to a proper error model can be shown. For re-
calibration the BaseRecalibrator component was made, which takes as input the
(sorted, duplicate marked and realigned) alignment BAM and the reference genome
ﬁles.
Masking ﬁles containing known variational regions are essential to include, otherwise
the error model will be quite useless. For human genomic sequencing a dbSNP ﬁle
and preferably also a reliable 1000 Genomes indels ﬁle should be used, as in the
realignment procedure. In exome analysis, an interval list of known exome regions
should additionally be included, in order that only captured sites are included in
the model creation.
The assumptions made by the model that relies on priors and the covariate modeling
accuracy is greatly improved when the mentioned ﬁles are incorporated. The output
is a base score recalibrated BAM ﬁle and optionally model plots. For before-and-
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after comparison two runs need to be made for covariate table creation and input
into the AnalyzeCovariates tool of GATK, which can easily be done using Anduril
using a custom function when needed.
3.4 Variant calling
The main question in sequencing projects is generally answered using the variant
information found. Variant calling is the critical step, in which the actual diﬀerences
in the alignment ﬁle compared to the reference genome are derived (step 5 in ﬁgure 2,
see also ﬁgure 5). The modern calling algorithms rely on probabilistic Bayesian error
model creation, which uses prior information about inherent genetic background
mutations frequencies and information found from known mutation sites such as
dbSNP.
Naturally, the reliability of each base being correctly sequenced and positioned must
be dynamically assessed. The improvements from the previous recalibration step
thus greatly enhance the accuracy of the variant calling step. Each variant is given
a probabilistic scoring value as an estimation of the reliability according to the model
of being a true variant.
The amount of variants called is dependent on the probabilistic threshold for in-
clusion, which can be changed to be suitable for the project at hand. When great
accuracy is needed the default or even more stringent threshold should be used. For
multi-sample data mining projects it might be reasonable to keep most if not even
all possible variants intact for ﬁltering or summarizing using diﬀerent criteria later
on.
The VariantCaller component for Anduril was created for calling purposes. It sup-
ports the standard high quality callers Samtools, VarScan and GATK. Samtools
is the most simple one, VarScan is especially used for copy number variations and
normal-tumor comparison analysis, while GATK is overall the most robust and fea-
tures dynamic multi-sample analysis capabilities and can use parallelized multi-core
processing for enhanced speed. The preferred caller is chosen using a parameter.
The newest GATK callers MuTect (for somatic data) and HaplotypeCaller are still
untested and not available in the current public sequencing bundle version.
The standard method takes as input one BAM alignment ﬁle and the reference
genome ﬁle and outputs a VCF (Variant Calling Format) variant table ﬁle containing
a list of SNPs and indels with probabilistic quality estimates and allele zygosity
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evaluations based on calculated allele frequencies at the loci. For normal-tumor
VarScan analysis the corresponding pairs of BAM ﬁles are input. For multi-sample
analysis a list of BAM ﬁles is provided as input (or a single multi-sample BAM ﬁle)
and the output will be a multi-sample VCF ﬁle that can be split by sample if needed.
GATK again relies heavily on prior information for its advanced probablistic model
and providing a dbSNP ﬁle as input is highly recommended. A metric ﬁle with
information such as the number of variants called will also be output, which can be
useful to include in the ﬁnal project report.
3.5 Variant analysis
The method of ﬁnal analysis of the variants heavily depends on the questions asked
and level of detail required. A traditional and natural way is visualization of the
variants e.g. at speciﬁc regions of interest using tools such as the Integrative Ge-
nomics Viewer (IGV), also distributed by the Broad Institute [Rob11, Tho13], or
Rikurator [Kat13, Kat16a], which will soon be known as BasePlayer [Kat16b]).
When the data is abundant, however, some ﬁltering needs to be done beforehand.
Annotating the variant list using known genomic information helps searching accord-
ing to speciﬁc context and ﬁltering out unwanted regions (steps 6 and 7 in ﬁgure
2). Various ﬁltering methods are commonly applied, sometimes multiple times in
succession, in order to reduce the number of variants until only high quality and
relevant ones are left. Next we will describe the most common methods used in
Anduril sequencing projects.
3.5.1 Variant recalibration
The golden standard for handling large amount of data is currently recalibration
of variants using machine learning techniques. This is one of the most comprehen-
sive and advanced features of GATK and is implemented in the Anduril component
VariantRecalibrator. The idea revolves around using as much background informa-
tion as possible, such as 1000 Genomes, known indels, HapMap, dbSNP and a huge
amount of samples simultaneously in a single run for dynamic processing of each
variant for evaluation of its signiﬁcance.
The process will considerably aﬀect the ratio of false positives to true negatives and
make decision-making easier and more accurate. The crude variant score estimates
from the calling algorithms contain multiple biases that will be taken into account in
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this procedure. The calibration will result in new quality score values, that will be
useful for ranking and ﬁltering and as exact estimates of truth values (comparable
to p-values) they can help in decision making.
The component takes as input a multi-sample VCF and the reference genome ﬁles
and outputs a recalibrated VCF ﬁle. Instead of a multi-sample VCF ﬁle a list
of single samples can be input. For the algorithm to work a suﬃcient number of
samples needs to be included. The required amount depends on the data type.
Exome data requires tens of samples, while whole genome data might work with
under ten. Dummy-samples can be included if the sample size is inadequate, e.g.
from a diﬀerent project of comparable data or from other available sources.
The algorithm additionally requires background data as described above, which can
be downloaded from the GATK server. Filter annotations for indels and SNPs
can be changed from the defaults using parameters and the truth threshold chosen
according to preference. The result is a recalibrated multi-sample VCF ﬁle that can
be further annotated and ﬁnally ﬁltered for results.
3.5.2 Annotation
There are numerous available tools in Anduril for annotating ﬁles containing ge-
netic data after conversion to common table format (CSV). One of the most robust
annotator softwares publicly available that have been implemented in Anduril is
Annovar [Wan10] and is included in a component bearing the same name. Other
implementations have also been created for various diﬀerent uses of the software.
The Annovar component will take as input the variant ﬁle in either CSV or VCF
format and output in the same format. Annovar has multiple methods for adding
information, namely region, gene and ﬁlter based annotation.
The research question asked deﬁnes which method(s) should be used. Gene infor-
mation is critical when speciﬁc genes are of interest, such as the breast and ovarian
cancer related gene BRCA (see section 4). Region based annotation is used when
more detail is required, such as codon or SNP information. Filter based annotation
includes information from various databases, such as 1000 Genomes (populational),
dbSNP (SNP/indel) or COSMIC (oncological) [For15]. The annotation method is
chosen using a parameter. The databases used need to be downloaded in advance
from the Annovar server.
The annotation capabilities of GATK have been progressively improved and can
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easily be implemented for use in Anduril. When CSV format annotation is used the
possibilities using Anduril are quite limitless. The annotated ﬁle is ﬁnally ready for
ﬁltering.
3.5.3 Filtering
Crude ﬁltering is often appropriate and suﬃcient when the question asked is clear
and amount of data small. For this the VariantSelector was created that uses GATK
for selection of variants according to applied criteria. Any information in the VCF
ﬁle can be used during selection. Dynamic logical manipulations and inclusion and
exclusion criteria can be employed by using the JEXL (Java Expression Language)
format.
The component takes as input the (recalibrated and annotated) variant VCF and
the reference genome ﬁles and outputs the selected variants in a new VCF ﬁle. A
comprehensively annotated variant ﬁle makes selections easier and more detailed.
Using a threshold value for the (recalibrated) probability based variant quality score
is also recommended for minimizing the amount of false positives in the results.
As in the annotation step, it might be better to switch to the CSV format at this
point. There are numerous components available for Anduril that manipulate CSV
table ﬁles. Additional information can easily be added as new columns and matrix
calculations are possible e.g. through R components. The main issue at this point
is the amount of data to be handled and some pre-ﬁltering is often needed to reduce
ﬁle sizes. One example is VariantFilter that uses the variant data in CSV format
and can annotate, compute allele counts and ﬁlter based on allele frequencies.
The ﬁnal variants are ready for manual analysis and interpretation. The ﬁnal form is
commonly a list of aﬀected genes and actual mutational changes and/or a graphical
representation e.g. as an integrated pathway plot using Moksiskaan [Laa10].
3.6 Parallelization
The two great advantages of Anduril is integration and parallelization. The integra-
tive approach enables any publicly available tool to be implemented for use in an
Anduril pipeline. Data from diﬀerent sources can be included and run in parallel
using multi-core systems, where each separate process will be distributed eﬃciently
and automatically in the (cloud) system until execution is completed.
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The pipeline method allows logical coupling of processes, which tells the Anduril
engine in what order to run the processes, when to wait for a process and how to
combine results from diﬀerent runs into a new process. Everything is distributed
automatically in an optimal way as long as the pipeline logic is correct. When
changes and iterations are made only parts of the pipeline that have been changed
will be run.
The parallelization is automatic for each separable independent process in the An-
duril pipeline code. For large sequencing projects, or simply when managing large
data ﬁles, intelligent pipeline coding can improve running times to that which is
only limited by the amount of processor cores (and memory) available. Most, if not
all, steps in sequencing can be split into smaller parts such as samples, chromosomes
or even smaller genomic chunks. Even a sizeable NGS sample can be analyzed from
the beginning to end in (minutes to) hours when split processing is used [Agg15].
Some parts of the pipeline rely on dynamic use of big amounts of data in a sin-
gle evaluation process for model creation, such variant score recalibration, which
however allows intrinsic multi-threading in GATK. Splitting of these kind of steps
needs to be done with care and with regard to the algorithmic requirements and
assumptions. Parallel processing can also be especially useful in the last analysis
stage, when a big amount of data requires iterations in diﬀerent ways.
Generally, chromosomes can be analyzed in parallel on separate cores in practically
any step on the analysis and results combined in the end. This methodology has yet
to be tested in real projects with Anduril, as sample-level parallelization has been
suﬃcient. However, an analogical approach to the implementation in the paral-
lelization pipeline Hadoop [Agg15], is easy to achieve in Anduril simply by genomic
splitting and looping through an array of split ﬁles. As mentioned before, as long
as the processes are independent and separable, the Anduril engine will take care of
parallelization automatically.
Splitting already on FASTQ level will allow practically any level of parallelization.
Merging and splitting of BAM ﬁles is simple using SAM format management tools,
such as Samtools or Picard-tools, which have been included into sequencing bundle
(e.g. BamCombiner). Anduril remote connection allows multi-node runs (as in
Hadoop), which means practically limitless use of cloud resources in a single run.
17
4 Results
In this chapter we will discuss how the Anduril sequencing pipeline was tested in
various projects in our lab. Diﬀerent setups were used in searching for an optimal
setting for handling large amount of data with a limited computational multi-core
system and limited amount of storage space. As our data storage capacities progres-
sively increased and multi-core systems became cloud based, more and more could
be handled in parallel.
The ﬁrst example for testing the system was a small exome analysis of chronic
myeloid leukemia (CML) patients provided by the Haematology Clinic of Helsinki
University Hospital. In the second example, we processed a vast exome TCGA
cohort of 180 breast cancer patients for further analysis done in our lab. In the
last and third example, we processed an exome TCGA cohort of 330 ovarian cancer
patients and queried the results through creation of a database of calibrated and
annotated variants.
4.1 Diﬀerence in drug response in CML patients
Paired normal and tumor whole exome sequencing samples were provided from 8
CML high-risk patients with the same clinical prognosis, of which 4 had responded
well to the treatment (group 1) and 4 had hardly responded at all (group 2). The
Haemotology Clinic had for a while tried to ﬁgure out how predict drug response
in otherwise seemingly equal high-risk patients and ﬁnd out why a marked propor-
tion failed to respond to therapy. Rationally, genetic comparison analysis of high
responders versus low responders was planned and analysed using acquired samples
at FIMM (Institute of Molecular Medicine Finland).
At that point our lab was using the FIMM cloud-based computational cluster for
many of our analysis and we were asked by the Haematology Clinic to re-analyze the
data. The preliminary results by FIMM had not resulted in any clinically relevant
mutational diﬀerences. Their pipeline did not diﬀer in any relevant manner to ours
(see ﬁgure 3) as most of the algorithms and softwares used were the same, but still
provided a good start for testing of the Anduril sequencing pipeline.
For alignment we used BWA using the standard settings for dynamic trimming
and mismatch-counts. Sorting and indexing was done using Samtools. Duplicates
were marked using Picard-tools. Local realignment and base score recalibration was
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Figure 3: The general workﬂow of the CML analysis. The raw FASTQ (FASTA with
Qualities) reads were aligned using the Align component. With DuplicateMarker
the BAM (Binary Sequence Alignment Map) alignment was marked for duplicates
and then realigned and recalibrated through BamRecalibrator. Calls were next cal-
culated using the VariantCaller component. The VCF (Variant Calling Format)
variants were lastly converted to CSV format with VCF2CSV component and an-
notated using various Anduril methods (e.g. NextGene component). The coloring
simply emphasizes the hierarchical change in representation of the data.
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then applied in succession using GATK according to the Best Practice at the time
[dAA13]. For variant calling we tried two separate methods. Firstly VarScan, as the
go-to method for normal-tumor paired somatic calling, was used to fetch the most
speciﬁc set of calls. Secondly, we wanted to try out the UniﬁedGenotyper of GATK
and did multi-sample variant calling separately for the normal and tumor samples.
Calling with GATK achieved roughly 10 times more variants. However, after ﬁltering
out the variants from the normal set there were somewhat more left in the VarScan
set of variants. VarScan separates somatic and germline variants automatically as
well as variants with loss-of-heterozygosity (LOH) according to statistical analysis
done dynamically during the calling. By combining the results, after annotating
using components available in Anduril for Ensembl gene information, we concluded
in concordance with the results from FIMM, that our analysis did not ﬁnd any
common variants in the samples in either group that would explain the diﬀerence in
treatment response.
4.2 Massive parallel processing of TCGA BRCA exomes
Next we wanted to test our pipeline and hardware system on a huge amounts of
exome data that could later be used and analyzed in a query-like manner in projects.
We had acquired massive processing power from CSC cloud consisting of 8 nodes
each with 24 modern processors and four times the amount in Gb of memory. We
integrated the Anduril framework to the virtual machines in each node that could
be logged into and used. Work could also be remotely sent as jobs by which multiple
nodes could be integrated and used in parallel. This allowed the full power of Anduril
in which each process is according to the workﬂow setup automatically sent to the
next available processor and the required memory reserved.
We used the same principle for analysis as in the previous section depicted in ﬁgure 3
on approximately 180 TCGA exome breast cancer normal-tumor pairs (i.e. 360 ﬁles)
[The12]. For downloading and handling TCGA data in a local database manner, we
had created separate tools for Anduril gathered in the TCGA component bundle.
Downloading and creation of the TCGA database is time consuming and complicated
and is outside the scope of this study [Wan16b].
We found that each sample could eﬀectively run on one node using one processor
and 4 Gb of allocated memory. Naturally, there would be no gain in using multiple
processing threads (and more memory) per sample, as with this many samples to
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analyze there would be no processors left to allocate. In previous settings (e.g. the
CML project in section 4.1), we had concluded that a proportion of 4 Gb of memory
for each processor was quite optimal in the current climate of algorithms and software
especially in exome analysis. If more memory per sample was needed, as might be
the case in whole genome projects, we could allocate more threads and memory for
each sample using the same proportion. Some downtime for processors is however
inevitable in this setup, as every algorithm does not allow intrinsic multithreading
(e.g. Picard sorting and VarScan calling).
It became apparent that the amount of input-output (IO) operations on the hard-
drives was problematic and slowed down the usage of the virtual machines and
sometimes crashes occurred. Also the amount of space required was massive. For
this project arguably 30 Gb (mean size of an exome sample) x 180 normal-tumor
pairs, i.e. (30 x 360) Gb = 10,8 Tb of storage space, was required at minimum. We
could minimize space requirements by using the inherent ability of Anduril engine to
dynamically remove ﬁles that have according to the workﬂow setup become obsolete.
This obviously created somewhat of a mess when crashes occurred, since some runs
needed to start from the beginning. However, with a working setup and obvious
hardware and storage limitations, this is of a huge advantage.
We additionally implemented the then new feature of space reduction of BAM ﬁles
in GATK into the component BamReducer, which could compress BAM ﬁles up to
100 times less size. The eﬀect on VarScan analysis was however unclear, so this was
mainly used as the last step for storing processed BAMs for possible later usage.
Finally, we acquired a lengthy list of VarScan analyzed normal-tumor variant VCF
ﬁles as well as multi-sample GATK analyzed variant VCF ﬁles (normal and tumor),
both with calls that could be annotated and queried for various projects. The
downloading, ﬁnal setup, testing, error corrections and iterative analysis due to
occurred problems required months to ﬁnish.
4.3 Database creation for TCGA OVAC exomes
Lastly, we wanted to add robust database querying of ﬁnalized variants for usage in
various projects into our sequencing methods. When a huge amount of variants is
available, the sheer amount of information provides complexity in choice of analysis
and required processing power. Our main focus was on creating readily annotated
and coordinate based genetic mutation information easily accessible either with or
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without cloud-based computing power. Conceptually, once the database has been
created, iterative querying, gathering and manipulation of information can when
necessary be split into e.g. chromosomal parallel processes that are integrated in
the end (see section 3.6). This allows the full power of a cloud based processing
system with the automated parallelization of Anduril to be used.
Since we and our collaborators were already interested in ﬁnding leading mutations
in ovarian cancer (OVAC) [Che15] using various methods, we downloaded and pro-
cessed the OVAC exome cohort available in TCGA to aid in this purpose [Bel11].
Approximately 330 normal-tumor pairs i.e. 660 samples all-in-all in raw sequencing
data was downloaded using the TCGA bundle components in the same manner as
in the BRCA project.
The same principal pipeline analysis was run through, this time with less errors and
more ﬂow due to multiple reﬁnements. A massive amount of storage space in tens of
Tb was required and lists of variants from both VarScan and GATK multi-sample
analysis were stored. Reduced (compressed) BAMs were stored for visualization and
possible analytical purposes.
The prototypical database components created enabled building of SQL tables from
variant (VCF) and annotation (CSV/VCF) information (see ﬁgure 4). If normal
and tumor samples were included into the same database an allele based subtraction
method was used to create a comparison database. The list of samples containing a
certain allele was conserved and allele counts were calculated into separate columns.
User-based dynamic manipulations were allowed in database creation for adding new
columns of information.
Querying was done using a separate component, which allowed robust calculations
and integrations to be made. Creation of an entire cohort database required a
huge amount of information and was shown to be quite processor-time and memory
consuming. Sub-genomic database creation of areas of interest provided to be fast
and practical. For creation of an entire database parallelization by chromosomes was
possible and allowed the utilization of the cloud based processing system to reduce
creation time linearly.
We tested the database by querying the BRCA1 and BRCA2 regions and compared
the results to those from another OVAC project in our lab [Che15]. The mutational
allele status was coherent with the TCGA analysis made, but failed to provide
anything novel (see appendix 1). An example that illustrates how the variants are
called from the data and how the subsequent variant analysis follows is shown in
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Figure 4: The principle of the prototypic database we created for sequencing variant
analysis. Multiple variant VCF (Variant Quality Format) samples are integrated
with CSV/VCF annotation information. If normal-tumor pairs are used subtraction
results are included. The database is created in SQL (Structured Query Language).
When querying various methods can be used, such as complex ﬁltering, dynamic
calculations and the information to be presented can be selected. For large databases
multi-threading can utilized by splitting the processing into separate parallelizable
genomic parts (e.g. chromosomes). The coloring simply emphasizes the change in
representation of the data.
23
ﬁgure 5. The database framework and implementation proved however to be quite
complex, cumbersome to maintain and diﬃcult to optimize. To date no stable
implementation is available in Anduril for public use, however it is still an ongoing
project.
5 Discussion
Next-generation sequencing (NGS) has evolved to the to-go method for genetic anal-
ysis since its emergence around 2005, when the ﬁrst sequencers were created. To
date, clinical genetic tests still rely on simple one- or multiple-gene methods either
by direct PCR-probing or micro-arrays. Following the current progress, it is quite
inevitable that future genetic tests will be based upon a once taken whole genome
sample, from which any variant of interest can be inferred. The genetic proﬁle of an
individual can subsequently be updated every few years to keep the information up
to date with advancements in technology.
In health care, a common phenotype-inducing variant can be of importance regard-
less of its prevalence through elevated risk for certain diseases or by changing the
kinetics of medicaments. The scope of utilities in this regard is quite limitless and
mostly bounded by imagination and law.
In this work we reviewed the current golden-standard methods for next-generation
sequence analysis. There are quite a few algorithms and software available for each
step along the pipeline, some faster than others, most however rather equally reliable
result-wise. The Best Practice for The Genome Analysis Toolkit (GATK), created
and distributed by Broad Institute in MIT/Harvard, has been used as a guideline
from the beginning in our work for both pipeline setup and choice of tools.
The most relevant GATK tools have been incorporated into the Anduril sequencing
bundle, such as tools for recalibration of alignments or variants and variant calling.
The common alignment tool BWA as well as the main duplicate marker from Picard-
tools have been recently incorporated into GATK, which has henceforth become
more or less a complete kit for analysis of NGS data.
We did not create any new core algorithms for NGS data processing. We included
some of the best available methods into the sequencing bundle for usage in Anduril.
The strength of Anduril comes from automatic parallelizaton of each run, which
can be a sample or genetic region such as chromosome. Further advantage comes
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Figure 5: In this example we have a hypothetical set of 3 samples each containing
3 reads of diﬀerent lengths aligned to the reference genome. The locus (human
GRCh37/hg19 assembly) is one of the SNP positions in BRCA1 that we found in
the OVAC TCGA data set. Hypothetically, the sample 1 variant is of high-quality
(3/3 alternates), while the sample 3 variant is of low-quality (only 2/3 alternates),
according to probabilistic signiﬁcance estimates. Using database annotations for
our data, we ﬁnd that the variant is not a signiﬁcant ovarian cancer tumor causing
mutation, does provide enhanced risk for breast cancer [Cox11] and in the population
occurs in 18-45 % as wild-type depending on ethnicity, which leaves our calculated
frequency of 49 % (see appendix 1) in tumor samples rather insigniﬁcant. This
variant thus oﬀers a bad candidate in the search of a disease causing mutation. The
(arbitrarily) colored boxes encompass annotation databases used and the dash-lined
boxes the overall process.
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from the ability to include essentially any tool available into the pipeline by easy
wrapping into an Anduril component.
The only restriction for incorporation into Anduril is ﬁle-based ﬂow of information.
This integrative approach enables us to use the core utilities of GATK, as well as the
ﬁnesses of other tools such as Annovar for annotations or pathway analysis tools such
as Moksiskaan, all in the same pipeline. We have also created numerous analysis
tools for answering speciﬁc questions often using R libraries and for accessing various
databases using SQL, that can be highly useful in certain projects [Laa10, Kar11,
Ova13, Lou13, Che15].
The core of the sequencing pipeline in Anduril was outlined in the methods sec-
tion in appropriate detail. The pipeline can be individualized through component
parameters. Disk space can be automatically minimized in Anduril using dynamic
scrapping of obsolete ﬁles during processing, which is highly useful in NGS projects
due to huge ﬁle sizes. When cloud based multi-processor systems are used the au-
tomatic parallelization of Anduril comes into full power. By intelligent splitting
(e.g. by chromosomes) most steps of whole genome data analysis can be done ex-
tremely fast, time only restricted by hardware, and as was mentioned in section 4.2
sometimes the frequency of IO-operations that the system can handle.
Through three examples in the results section the evolution of the sequencing pipeline
was narrated. The core was created in the ﬁrst example where a small group of
chronic myeloid leukemia exomes were re-analyzed. We were asked to mine the
samples once more for any shared variants that could explain diﬀerences in response
to treatment between the groups of High- versus Low-responders. Even though no
likely causal variants could be found in this small experiment, the analysis proved
Anduril could be eﬀectively used in NGS analysis and enabled us to experiment with
parallelization.
Our upgraded cloud-based system (8 nodes x 24 processors with 4 Gb memory each)
was put to test in the second example, in which we processed a huge cohort of 180
normal-tumor paired breast cancer (BRCA) exomes from the TCGA database. We
reﬁned the pipeline, created more tools and experimented with large-scale process-
ing. After months of trial and errors we completed the analysis in full and lists
of VarScan and GATK (variant recalibrated) variants were available for use in our
projects for reference.
A database approach for analysis of variants has been an ongoing project in our
lab. In the third example, we processed roughly 330 normal-tumor pairs of ovarian
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cancer (OVAC) exomes from the TCGA database using roughly the same pipeline
as in the BRCA analysis. This time we experimented with post-processing the
data with our prototypic database component. Variant and annotation information
could be combined and various manipulation be made through complex querying of
information from the database.
The database was tested for estimation of BRCA1 and BRCA2 mutation frequen-
cies in OVAC prognostic groups (see appendix 1), by which the ﬁndings were con-
sistent with those otherwise achieved [Che15]. The database however proved to
be cumbersome to maintain and make eﬃcient. More work is still required before
post-prototypical component can be made publicly available. As a principle, paral-
lelization through parts in database creation and search can make iterative analysis
very fast and convenient even for huge amounts of data when cloud-system based
hardware is available.
Compared to other comprehensive NGS pipeline tools, we believe Anduril can of
great use to the programming oriented scientist. For multi-processor (cloud) sys-
tems, the automatic distribution of parts in a workﬂow, while maintaining the hi-
erarchical order by waiting for connected parts to ﬁnish, makes Anduril a powerful
tool in large-scale analysis. Favorite software can easily be wrapped into the pipeline
and current tools are fully available to be used in any project.
Maintenance of components in the ever-changing climate of tools and updates re-
mains a great challenge. Even without a fully working database component for
post-analysis, the sequencing bundle now serves as a complete kit for NGS analysis
for use in eﬃcient search of cancer driving genes and therapeutic targets.
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Appendix 1. OVAC BRCA1/2 Mutations
Figure 6: Summary of BRCA mutations from the OVAC TCGA project (see section
4.3). Not all samples passed the quality control (QC) ﬁlters of the variant callers.
The loci (human GRCh37/hg19 assembly) and alleles are shown in the green columns
and the (most relevant) annotations (Ensembl, ClinVar) are in the middle yellow
columns. The last blue columns show the number of tumor samples that have the
alternate allele (alt) called at that position, the number with the reference allele
(ref) and ﬁnally the proportion in percentage containing the mutated status (freq).
The mutations with highest mutations frequency are in bold, with an arbitrary
cut-oﬀ value of 20 %. Mutations that did not pass the default caller thresholds for
high-quality variants were omitted, as well as mutations supported by only 1 sample.
Chr = chromosome, Pos = genomic position, Ref = reference allele, Alt = alternate
(variant) allele.
